Synthesis of the Phosphono Analogue of the Dimeric Subunit of Neisseria ­meningitidis Type A Capsular Polysaccharide

Abstract

The development of a glycoconjugate vaccine against N. meningitidis type A bacterium is greatly hampered by the chemical lability of the phosphodiester bridges joining the N-acetyl ­mannosamine repeating units of its capsular polysaccharide. We ­describe the first synthesis of the phosphonodisaccharide α-d-ManpNAc-[1→CH₂-P(O)(O^-)→6]-β-d-ManpNAc-(1→O) (CH₂)₃NH₂ as a stable analogue of the corresponding phosphate-bridged disaccharide. The key phosphonoester linkage is obtained by condensation of monosaccharide building blocks under Mitsunobu conditions. Moreover, the protected precursor of the target compound is suitably designed to allow further elongation and synthesis of higher oligomers.

carbohydrates - Mitsunobu reaction - phosphonates - protecting groups - glycoconjugate vaccines

References

1 Jones C. Carbohydrates in Europe  1998,  21:  10 

2a Lindberg AA. Vaccine  1999,  17:  S28 

2b Morley SL. Pollard AJ. Vaccine  2002,  20:  666 

3a Gold R. Lepow ML. Goldschneider I. Gotschlich EC. J. Infect. Dis.  1977,  136:  S31 

3b Reingold AL. Broome CV. Hightower AW. Ajello GW. Bolan GA. Adamsbaum C. Jones EE. Phillips C. Tiendrebeogo H. Yada A. Lancet  1985,  2:  114 

4a Pozsgay V. In Advances in Carbohydrate Chemistry and Biochemistry   Vol. 56:  Tipson RS. Horton D. Academic Press; New York: 2000.  p.153 

4b Ravenscroft N. Jones C. Curr. Opin. Drug Discovery Dev.  2000,  3:  222 

5a Bishop CT. Jennings HJ. In The Polysaccharides   Vol. 16:  Aspinall GO. Academic Press; New York: 1982.  p.292 

5b Jennings HJ. In Advances in Carbohydrate Chemistry and Biochemistry   Vol. 41:  Tipson RS. Horton D. Academic Press; New York: 1983.  p.155 

5c Arndt B. Porro M. In Immunobiology of Proteins and Peptides VI   Atassi MZ. Plenum Press; New York: 1991.  p.129 

6a Schneerson R. Barrera O. Sutton A. Robbins JB. J. Exp. Med.  1980,  152:  361 

6b Robbins JB. Schneerson R. Anderson P. Smith DH. J. Am. Med. Assoc.  1996,  276:  1181 

7a Pozsgay V. J. Org. Chem.  1998,  63:  5983 

7b Pozsgay V. Chu C. Pannell L. Wolfe J. Robbins JB. Schneerson R. Proc. Natl. Acad. Sci. U.S.A.  1999,  96:  5194 

8 Verez-Bencomo V. Fernandez-Santana V. Hardy E. Toledo ME. Rodriguez MC. Heynngnezz L. Rodriguez A. Baly A. Herrera L. Izquierdo M. Villar A. Valdés Y. Cosme K. Deler ML. Montane M. Garcia E. Ramos A. Aguilar A. Medina E. Toraño G. Sosa I. Hernandez I. Martinez R. Muzachio A. Carmenates A. Costa L. Cardoso F. Campa C. Diaz M. Roy R. Science  2004,  305:  522 

9a Bundle DR. Smith ICP. Jennings HJ. J. Biol. Chem.  1974,  249:  83 

9b Lemercinier X. Jones C. Biologicals  2000,  28:  175 

10 Costantino P, Berti F, Norelli F, and Bartoloni A. inventors; Int. Appl. WO  03/080678 A1.  ; Chem. Abstr. 2003, 139, 275732

Reviews:

11a Engel R. Chem. Rev.  1977,  77:  349 

11b Nicotra F. In Carbohydrate Mimics   Chapleur Y. Wiley-VCH; Weinheim: 1998.  p.67 

11c Compain P. Martin OR. Bioorg. Med. Chem.  2001,  9:  3077 

See also:

11d Vargas LA. Miao LX. Rosenthal AF. Biochim. Biophys. Acta  1984,  796:  123 

11e Blackburn GM. Thatcher GR. Taylor GE. Prescott M. McLennan AG. Nucleic Acids Res.  1987,  15:  6991 

11f Biller SA. Forster C. Gordon EM. Harrity T. Scott WA. Ciosek CP. J. Med. Chem.  1988,  31:  1869 

11g Bartlett PA. Hanson JE. Giannousis PP. J. Org. Chem.  1990,  55:  6268 

11h Morgan BP. Scholtz JM. Ballinger MD. Zipkin ID. Bartlett PA. J. Am. Chem. Soc.  1991,  113:  297 

11i Orsini F. Di Teodoro E. Tetrahedron: Asymmetry  2002,  13:  1307 

11l Wen X. Hultin PG. Tetrahedron Lett.  2004,  45:  1773 

12a Cipolla L. Lay L. Nicotra F. Panza L. Russo G. J. Chem. Soc., Chem. Commun.  1995,  1993 

12b Casero F. Cipolla L. Lay L. Nicotra F. Panza L. Russo G. J. Org. Chem.  1996,  61:  3428 

13 Draghetti V. Poletti L. Prosperi D. Lay L. J. Carbohydr. Chem.  2001,  20:  813 

14a Babirad SA. Wang Y. Kishi Y. J. Org. Chem.  1987,  52:  1370 

14b Kobertz WR. Bertozzi CR. Bednarski MD. Tetrahedron Lett.  1992,  33:  737 

14c Bertozzi CR. Bednarski MD. Tetrahedron Lett.  1992,  33:  3109 

15

All new compounds gave satisfactory analytical and spectroscopic data.

16 Staudinger H. Meyer J. Helv. Chim. Acta  1919,  2:  635 

17 Garegg PJ. Samuelsson B. J. Chem. Soc., Perkin Trans. 1  1980,  2866 

18 Wang MF. Crilley MML. Golding BT. McInally T. Robinson DH. Tinker A. J. Chem. Soc., Chem. Commun.  1991,  667 

19

Spectroscopic and analytical data of compound 11: [α]_D ²⁵ +20.7 (c 1.0, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 7.37-7.19 (m, 15 H, Ph), 5.87 (d, 1 H, J = 9.3 Hz, NH), 4.65, 4.56 (each d, each 1 H, J _gem = 11.7 Hz, CH ₂ Ph), 4.55, 4.51 (each d, each 1 H, J _gem = 11.9 Hz, CH ₂ Ph), 4.46, 4.41 (each d, each 1 H, J _gem = 11.5 Hz, CH ₂ Ph), 4.36 (dt, 1 H, J _2,1 = 3.5 Hz = J _2,3, H-2), 4.16 (m, 1 H, H-1), 4.00 (dd, 1 H, J _5,6a = _5.1 = J _5,4, J _5,6b = 9.7 Hz, H-5), 3.82 (dd, 1 H, J _6a,6b = 10.0, H-6a), 3.78-3.69 (m, 3 H, H-3, H-4, H-6b), 3.74 (d, 3 H, J _Me,P = 11.3 Hz, OMe), 3.71 (d, 3 H, J _Me,P = 11.3 Hz, OMe), 2.13 (dt, 1 H, J _7a,1 = 9.3 Hz, J _7a,7b = 15.7 Hz = J _7a,P, H-7a), 2.04 (dt, 1 H, J _7b,1 = 4.0 Hz, J _7b,P = 15.7 Hz, H-7b), 1.87 (s, 3 H, COCH ₃). ¹³C NMR (100.6 MHz, CDCl₃): δ = 170.37 (CO), 138.39, 138.27, 137.74 (C ipso), 129.19-128.15 (Ph), 76.49 (C-3), 74.06 (C-5), 73.81, 73.35, 72.31 (3 CH ₂ Ph), 72.31 (C-4), 68.79 (C-1), 68.69 (C-6), 53.26 (d, J _OMe,P = 5.9 Hz, OMe), 52.60 (d, J _OMe,P = 5.9 Hz, OMe), 45.28 (d, J _2,P = 14.8 Hz, C-2), 28.06 (d, J _7,P = 142.0 Hz, C-7), 23.71 (COCH₃). ³¹P NMR (162 MHz, CDCl₃): δ = 32.48. HRMS (MALDI): m/z calcd for C₃₂H₄₀NO₈PNa: 620.2389 [M + Na⁺]; found: 620.2386; m/z calcd for C₃₂H₄₀NO₈PK: 636.2129 [M + K⁺]; found: 636.2132.

20 Müller B. Martin TJ. Schaub C. Schmidt RR. Tetrahedron Lett.  1998,  39:  509 

21 Yang G. Ding X. Kong F. Tetrahedron Lett.  1997,  38:  6725 

22 Malachowski WP. Coward JK. J. Org. Chem.  1994,  59:  7616 

23a Norbeck DW. Kramer JB. Lartey PA. J. Org. Chem.  1987,  52:  2174 

23b Campbell DA. J. Org. Chem.  1992,  57:  6331 

23c Malachowski WP. Coward JK. J. Org. Chem.  1994,  59:  7625 

23d Pungente MD. Weiler L. Org. Lett.  2001,  3:  643 

23e Borodkin VS. Milne FC. Ferguson MAJ. Nikolaev AV. Tetrahedron Lett.  2002,  43:  7821 

24

A fraction containing a single phosphorous diastereoisomer of 16 was isolated during column chromatography and fully characterized: [α]_D ²⁵ +8.1 (c 0.25, CHCl₃). ¹H NMR (500 MHz, CDCl₃): δ = 8.25 (br s, 1 H, NH), 7.46-7.25 (m, 25 H, Ph), 5.76 (br d, 1 H, NH), 5.28 (br s, 1 H, NH), 5.11 (s, 2 H, CH ₂ Ph Z), 4.95, 4.60 (each d, each 1 H, J _gem = 10.7 Hz, CH ₂ Ph), 4.89 (1 H, overlapping signal, H-2), 4.89, 4.51 (each d, each 1 H, J _gem = 10.9 Hz, CH ₂ Ph), 4.66, 4.59 (each d, each 1 H, J _gem = 11.8 Hz, CH ₂ Ph), 4.49, 4.42 (each d, each 1 H, J _gem = 11.9 Hz, CH ₂ Ph), 4.45 (br s, 1 H, H-1), 4.37-4.29 (m, 2 H, H-2′, H-6a), 4.22 (br dd, 1 H, J _6a,6b = 12.0 Hz, H-6b), 4.14 (m, 1 H, H-1′), 4.04 (dd, 1 H, J _{3 ′ ,4 ′} = 9.7 Hz, J _{3 ′ ,2 ′} = 5.4 Hz, H-3′), 3.92-3.77 (m, 6 H, H-4, H-7a, H-4′, H-5′, H-6′a, H-6′), 3.75 (d, 3 H, J _Me,P = 10.9 Hz, OMe), 3.69 (dd, 1 H, J _3,4 = 8.3 Hz, J _3,2 = 3.7 Hz, H-3), 3.58 (m, 1 H, H-7b), 3.38 (br d, 1 H, J _5,4 = 9.5 Hz, H-5), 3.27 (m, 2 H, H-9a, H-9b), 2.23-2.06 (m, 2 H, H-7′a, H-7′b), 1.84 (br s, 6 H, COCH ₃ ), 1.78 (m, 2 H, H-8a, H-8b). ¹³C NMR (125.7 MHz, CDCl₃): δ = 171.62 (CO), 169.82 (CO), 156.52 (CO Z), 138.21 (2 × C), 137.92, 137.61, 137.11 (C ipso), 128.73-127.80 (Ph), 99.57 (C-1), 79.88 (C-3), 75.92, 73.01, 71.81 (C-4, C-4′, C-5′), 75.24, 73.35, 72.80, 71.06 (4 CH₂Ph), 74.51 (C-5), 73.75 (C-3′), 68.24 (C-1′), 68.21 (C-6′), 67.49 (C-7), 66.79 (d, J _6,P = 38.5 Hz, C-6), 66.54 (CH₂Ph Z), 53.87 (d, J _OMe,P = 6.8 Hz, OMe), 49.94 (C-2), 48.68 (d, J _{2 ′ ,P} = 12.8, C-2′), 38.46 (C-9), 30.81 (C-7′), 29.64 (C-8), 23.98 (COCH₃), 23.31 (COCH₃). ³¹P NMR (202.5 MHz, CDCl₃): δ = 29.71. HRMS (ESI): m/z calcd for C₅₇H₇₀N₃O₁₅PNa: 1090.4436 [M + Na⁺]; found: 1090.4410.

25

Spectroscopic and analytical data of compound 17: [α]_D ²⁵ -40.5 (c 1.0, CHCl₃). ¹H NMR (400 MHz, CDCl₃): δ = 7.78 (br s, 1 H, NH), 7.34-7.20 (m, 30 H, Ph), 5.92 (d, 1 H, J = 8.9 Hz, NH), 5.14 (s, 2 H, CH ₂ Ph Z), 4.98, 4.62 (each d, each 1 H, J _gem = 10.8 Hz, CH ₂ Ph), 4.98, 4.52 (each d, each 1 H, J _gem = 10.8 Hz, CH ₂ Ph), 4.80 (br dd, 1 H, H-2), 4.74, 4.50 (each d, each 1 H, J _gem = 11.3 Hz, CH ₂ Ph), 4.63-4.52 (m, 3 H, H-1, H-2′, H-6a), 4.54, 4.47 (each d, each 1 H, J _gem = 11.4 Hz, CH ₂ Ph), 4.42, 4.32 (each d, each 1 H, J _gem = 12.1 Hz, CH ₂ Ph), 4.26 (m, 1 H, H-1′), 4.18 (br dd, 1 H, J _6a,6b = 11.4 Hz, H-6b), 3.98-3.87 (m, 3 H, H-4, H-5′, H-7a), 3.81-3.79 (m, 3 H, H-3′, H-4′, H-6′a), 3.73 (dd, 1 H, J _{6 ′ b,6 ′ a} = 9.7 Hz, J _{6 ′ b,5} = 2.9 Hz, H-6′b), 3.68 (dd, 1 H, J _3,2 = 3.5 Hz, J _3,4 = 9.4 Hz, H-3), 3.53 (br s, 1 H, H-7b), 3.39 (d, 1 H, J _5,4 = 9.5 Hz, H-5), 3,34 (m, 1 H, H-9a), 3.10 (m, 1 H, H-9b), 2.27 (dt, 1 H, J _{7 ′ a,1 ′} = 10.2 Hz, J _{7 ′ a,7 ′ b} = 16.8 Hz = J _{7 ′ a,P}, H-7′a), 2.07 (1 H, overlapping signal, H-7′b), 2.07 (s, 3 H, COCH ₃ ), 1.85 (s, 3 H, COCH ₃ ), 1.73 (m, 2 H, H-8a, H-8b). ¹³C NMR (100.6 MHz, CDCl₃): δ = 171.79 (CO), 169.88 (CO), 159.46 (CO Z), 138.34 (2 × C), 138.11, 138.02, 137.87 (2, C ipso), 128.58-127.66 (Ph), 97.27 (C-1), 80.12 (C-3), 76.82 (C-3′), 75.38, 73.86, 73.30, 71.37, 70.74 (5 CH₂Ph), 73.86 (C-5), 73.10 (C-4′), 72.74 (C-4, C-5′), 71.05 (C-1′), 68.40 (C-6′), 67.62 (CH₂Ph Z), 65.13 (d, J _6,P = 37.8 Hz, C-6), 62.09 (C-7), 49.47 (C-2), 48.90 (d, J _{2 ′ ,P} = 15.3, C-2′), 37.40 (C-9), 28.76 (d, J _{7 ′ ,P} = 147.6 Hz, C-7′), 27.21 (C-8), 23.42 (COCH₃), 22.94 (COCH₃). ³¹P NMR (202.5 MHz, CDCl₃): δ = 24.83. HRMS (MALDI): m/z calcd for C₆₃H₇₃N₃O₁₅PNa: 1166.4677 [M + H⁺]; found: 1167.4669; m/z calcd for C₆₃H₇₃N₃O₁₅PNa₂: 1188.4575 [M + H + Na⁺]; found: 1189.4552.

26

Spectroscopic and analytical data of compound 1: [α]_D ²⁵ -17.8 (c 1.0, H₂O). ¹H NMR (400 MHz, D₂O): δ = 4.94 (d, 1 H, J _1,2 = 1.7 Hz, H-1), 4.69 (1 H, overlapped by HDO signal, H-2), 4.51 (br dd, 1 H, H-2′), 4.38-4.23 (m, 3 H, H-1′, H-6a, H-6b), 4.17-4.08 (m, 2 H, H-3′, H-7a), 4.02-3.93 (m, 4 H, H-3, H-7b, H-6′a, H-6′b), 3.81-3.73 (m, 3 H, H-4, H-4′, H-5′), 3.66 (m, 1 H, H-5), 3.26 (br t, 2 H, J = 7.5 Hz, H-9a, H-9b), 2.40-2.27 (m, 2 H, H-7′a, H-7′), 2.22 (s, 3 H, COCH ₃ ), 2.20 (s, 3 H, COCH ₃ ), 2.11 (m, 2 H, H-8a, H-8b). ¹³C NMR (100.6 MHz, D₂O): δ = 175.73 (CO), 174.60 (CO), 99.73 (C-1), 75.63 (C-5), 74.44, 67.70, 66.90 (C-4, C-4′, C-5′), 72.84 (C-1′), 71.86 (C-3), 69.57 (C-3′), 67.97 (C-7), 63.38 (C-6), 60.77 (C-6′), 53.27 (C-2), 53.05 (d, J _{2 ′ ,P} = 9.7 Hz, C-2′), 38.02 (C-9), 27.80 (d, J _{7 ′ ,P} = 134.6 Hz, C-7′), 26.85 (C-8), 22.31 (2 COCH₃). ³¹P NMR (162 MHz, D₂O): δ = 22.95. HRMS (ESI): m/z calcd for C₂₀H₃₈N₃O₁₃PNa: 582.2034 [M + H⁺]; found: 582.2035; m/z calcd for C₂₀H₃₇N₃O₁₃PNa₂: 604.1853 [M + Na⁺]; found: 604.1857.